Growth Differentiation Factor 15 in Heart Failure: An Update
- 9 September 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Heart Failure Reports
- Vol. 9 (4), 337-345
- https://doi.org/10.1007/s11897-012-0113-9
Abstract
Growth differentiation factor 15 (GDF-15) is a stress-responsive cytokine expressed in the cardiovascular system. GDF-15 is emerging as a biomarker of cardiometabolic risk and disease burden. GDF-15 integrates information from cardiac and extracardiac disease pathways that are linked to the incidence, progression, and prognosis of heart failure (HF). Increased circulating levels of GDF-15 are associated with an increased risk of developing HF in apparently healthy individuals from the community. After an acute coronary syndrome, elevated levels of GDF-15 are indicative of an increased risk of developing adverse left ventricular remodeling and HF. In patients with established HF, the levels of GDF-15 and increases in GDF-15 over time are associated with adverse outcomes. The information provided by GDF-15 is independent of established risk factors and cardiac biomarkers, including BNP. More studies are needed to elucidate how the information provided by GDF-15 can be used for patient monitoring and formulating treatment decisions. Further understanding of the pathobiology of GDF-15 may lead to the discovery of new treatment targets in HF.Keywords
This publication has 91 references indexed in Scilit:
- Aging-Associated Cardiovascular Changes and Their Relationship to Heart FailureHeart Failure Clinics, 2012
- Diabetes and the Risk of Heart FailureHeart Failure Clinics, 2012
- In search of new therapeutic targets and strategies for heart failure: recent advances in basic scienceThe Lancet, 2011
- Desmoglein 2 mutant mice develop cardiac fibrosis and dilationBasic Research in Cardiology, 2011
- Telomere dysfunction induces metabolic and mitochondrial compromiseNature, 2011
- Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxisThe Journal of Experimental Medicine, 2011
- Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapyEuropean Heart Journal, 2009
- Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2009
- A p53-type response element in the GDF15 promoter confers high specificity for p53 activationBiochemical and Biophysical Research Communications, 2007
- A gene atlas of the mouse and human protein-encoding transcriptomesProceedings of the National Academy of Sciences of the United States of America, 2004